TriaGen Wealth Management’s CVS Health CVS Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
Sell
-11,545
Closed -$916K 178
2025
Q4
$916K Hold
11,545
0.24% 86
2025
Q3
$870K Sell
11,545
-137
-1% -$9.39K 0.23% 95
2025
Q2
$806K Buy
11,682
+56
+0.5% +$3.67K 0.24% 88
2025
Q1
$788K Buy
+11,626
New +$696K 0.28% 76
2022
Q2
Sell
-8,247
Closed -$835K 167
2022
Q1
$835K Buy
8,247
+5,497
+200% +$577K 0.43% 66
2021
Q4
$284K Sell
2,750
-970
-26% -$89.6K 0.14% 147
2021
Q3
$316K Buy
+3,720
New +$312K 0.17% 138

Other funds holding CVS

TriaGen Wealth Management's CVS Position: Q1 2026 in Review

TriaGen Wealth Management sold out of CVS Health (CVS) in Q1 2026, closing a stake of 11,545 shares — an estimated $916K sold.

TriaGen Wealth Management first reported a position in CVS in Q3 2021 and held it in 7 quarters. The position peaked at $916K in Q4 2025. 1,876 funds tracked by Wall St. Rank hold CVS as of Q1 2026.

  • TriaGen Wealth Management reported no remaining CVS Health position as of Q1 2026 after selling out during the quarter.
  • TriaGen Wealth Management sold 11,545 CVS Health shares in Q1 2026, an estimated $916K.
  • TriaGen Wealth Management first reported a position in CVS Health in Q3 2021 and held it in 7 quarters.
  • TriaGen Wealth Management's CVS Health position peaked at $916K in Q4 2025.
  • 1,876 funds tracked by Wall St. Rank held CVS Health as of Q1 2026.

Based on TriaGen Wealth Management's 13F filing for Q1 2026, filed 29 Apr 2026.